BRIEF-U.S. FDA accepts regulatory submission for lynparza By: Reuters: Company News October 18, 2017 at 08:58 AM EDT * U.S. FDA accepts regulatory submission for lynparza® (olaparib) in metastatic breast cancer and grants priority review Read More >> Related Stocks: Merck & Co